Abstract
A case of Creutzfeldt-Jakob disease treated with amantadine showed considerable initial improvement, followed by a period of almost five years during which the patient remained in a relatively stable condition until he died accidentally. The diagnosis was confirmed histologically.
Full text
PDF![960](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff79/490372/f6e1ab0f6005/jnnpsyc00090-0088.png)
![961](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff79/490372/10f99a414ca7/jnnpsyc00090-0089.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Manuelidis E. E., Manuelidis L., Pincus J. H., Collins W. F. Transmission, from man to hamster, of Creutzfeldt-Jakob disease with clinical recovery. Lancet. 1978 Jul 1;2(8079):40–42. doi: 10.1016/s0140-6736(78)91345-4. [DOI] [PubMed] [Google Scholar]
- Matthews W. B. Epidemiology of Creutzfeldt-Jakob disease in England and Wales. J Neurol Neurosurg Psychiatry. 1975 Mar;38(3):210–213. doi: 10.1136/jnnp.38.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanders W. L., Dunn T. L. Creutzfeldt-Jakob disease treated with amantidine. A report of two cases. J Neurol Neurosurg Psychiatry. 1973 Aug;36(4):581–584. doi: 10.1136/jnnp.36.4.581. [DOI] [PMC free article] [PubMed] [Google Scholar]